Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center.

University Equine Veterinary Services, Findlay, OH 45840, USA.
Journal of Veterinary Internal Medicine (Impact Factor: 2.22). 01/2007; 21(1):157-65. DOI: 10.1892/0891-6640(2007)21[157:OONDCB]2.0.CO;2
Source: PubMed

ABSTRACT Equine herpesvirus type 1 (EHV-1) infection causes neurologic disease in horses. However, risk factors for the disease and long-term prognosis are poorly characterized.
There are identifiable risk factors for equine herpes-1 myeloencephalopathy.
The entire population of 135 horses housed within the equestrian facility.
A descriptive study investigated the clinical, serologic, virologic, and management aspects of an outbreak of EHV-1 myeloencephalopathy.
Out of 135 horses at the facility, 117 displayed signs of EHV-1 infection. Forty-six horses developed neurologic deficits characterized by symmetrical hind limb ataxia and weakness. Twelve horses that developed neurologic deficits became recumbent and did not survive. The development of severe neurologic deficits during the outbreak was associated with the presence of residual deficits at the 6-month examination. Within 1 year of the outbreak onset, all horses that survived had returned to an exercise level comparable to that experienced before the outbreak. Factors associated with the development of neurologic disease included age of > 5 years, location in the south or arena stall areas, and highest rectal temperature on day 3 or later of the febrile period.
Being > 5 years of age, having had a rectal temperature of > 103.5 degrees F, and highest rectal temperature occurring on or after the 3rd day of the febrile period were the factors most predictive of the development of neurologic disease and death. Data obtained during this outbreak substantiate previous findings relating to clinical aspects and diagnosis of EHV-1 myeloencephalopathy. The prophylactic and therapeutic use of acyclovir during this outbreak is described.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: A particularly severe equine herpesvirus type 1 (EHV-1) abortion outbreak occurred at a breeding farm in northern Germany. Sixteen of 25 pregnant mares that had received regular vaccination using an inactivated vaccine aborted and two gave birth to weak non-viable foals in a span of three months, with 89% of cases occurring within 40 days after the initial abortion case. Virological examinations revealed the presence of EHV-1 in all cases of abortion and serological follow-up in mares confirmed recent infection. Molecular studies identified a neuropathogenic variant (Pol/ORF30 A2254 to G2254) that belonged to geographical group 4 of EHV-1 isolates. The abortion outbreak was preceded by a case of mild ataxia of unknown cause in a mare that aborted four months after the ataxic episode. Although vaccination of pregnant mares did not prevent abortion, good EHV-1 immune status of the population at the time of outbreak may have had an impact in the failure of manifestation of the neurological form of the disease.
    Veterinary Microbiology 07/2014; 172(3-4). DOI:10.1016/j.vetmic.2014.06.023 · 2.73 Impact Factor
  • 08/2013; 25(8). DOI:10.1111/eve.12044
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The UL24 gene of Equine herpes virus type 1 is conserved across many herpesviruses, but its protein product has not been identified. We expressed the UL24 gene in Glutathione S-transferase (GST) Gene Fusion System. SDS-PAGE analysis revealed that the recombinant protein UL24 (pUL24) was not overexpressed in Escherichia coli BL21 host cells after induction by different IPTG concentrations, temperatures and times. That was attributed to transmembrane cytotoxic effects of the protein. The N terminus containing the first 477 bp was deleted and the remaining C terminus 342 bp was cloned into PGEX-6p-1 for construction of a recombinant plasmid PGEX-6p-1/UL24C. SDS-PAGE analysis revealed that the recombinant protein UL24C (pUL24C) was overexpressed in Escherichia coli BL21 host cells. The UL24 c-terminus protein about 11 KDa named pUL24C was purified and used to immunize guinea pig, producing polyclonal antibody. In immunoblotting experiments, this antiserum recognized a 37KDa protein in lysates from infected cells. The specificity and sensitivity of anti-pUL24C serum were detected with Agar gel immunodiffusion reaction. The pUL24C polyclonal antibody can be used for further characterization concerning the dynamic expression of UL24 protein and intracellular localization of UL24 protein in EHV-1 infected cells.

Full-text (2 Sources)

Available from
Jun 5, 2014

Similar Publications